Thomas J. Schall
2012
In 2012, Thomas J. Schall earned a total compensation of $6.5M as President and Chief Executive Officer at ChemoCentryx, a 888% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $219,333 |
|---|---|
| Option Awards | $5,748,591 |
| Salary | $482,051 |
| Other | $690 |
| Total | $6,450,665 |
Schall received $5.7M in option awards, accounting for 89% of the total pay in 2012.
Schall also received $219.3K in non-equity incentive plan, $482.1K in salary and $690 in other compensation.
Rankings
In 2012, Thomas J. Schall's compensation ranked 863rd out of 11,487 executives tracked by ExecPay. In other words, Schall earned more than 92.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 863 out of 11,487 | 93rd |
Division Manufacturing | 316 out of 4,253 | 93rd |
Major group Chemicals And Allied Products | 72 out of 1,203 | 94th |
Industry group Drugs | 39 out of 925 | 96th |
Industry Pharmaceutical Preparations | 35 out of 700 | 95th |
Source: SEC filing on April 10, 2014.
Schall's colleagues
We found three more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2012.